Patents by Inventor Norman R. Lazarus

Norman R. Lazarus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biologically active amides
    Patent number: 4355025
    Abstract: A polypeptide, designated Pancreatic Hormone III, together with pharmaceutically acceptable salts or metal complexes thereof; pharmaceutical formulations of the said polypeptide or its salts or complexes and the preparation of such formulations; and the use of the said polypeptide, salts and complexes in human and veterinary medicine in effecting a reduction in weight or in appetite or in the treatment of obesity, hyperglycaemia or hyperinsulinaemia.
    Type: Grant
    Filed: February 6, 1979
    Date of Patent: October 19, 1982
    Assignee: Burroughs Wellcome Co.
    Inventor: Norman R. Lazarus
  • Biologically active amides
    Patent number: 4223017
    Abstract: A polypeptide, designated Pancreatic Hormone III, together with pharmaceutically acceptable salts or metal complexes thereof; pharmaceutical formulations of the said polypeptide or its salts or complexes and the preparation of such formulations; and the use of the said polypeptide, salts and complexes in human and veterinary medicine in effecting a reduction in weight or in appetite or in the treatment of obesity, hyperglycaemia or hyperinsulinaemia.
    Type: Grant
    Filed: February 8, 1979
    Date of Patent: September 16, 1980
    Assignee: Burroughs Wellcome Co.
    Inventor: Norman R. Lazarus
  • Biologically active amides
    Patent number: 4175122
    Abstract: A polypeptide, designated Pancreatic Hormone III, together with pharmaceutically acceptable salts or metal complexes thereof; pharmaceutical formulations of the said polypeptide or its salts or complexes and the preparation of such formulations; and the use of the said polypeptide, salts and complexes in human and veterinary medicine in effecting a reduction in weight or in appetite or in the treatment of obesity, hyperglycaemia or hyperinsulinaemia.
    Type: Grant
    Filed: November 15, 1977
    Date of Patent: November 20, 1979
    Assignee: Burroughs Wellcome Co.
    Inventor: Norman R. Lazarus